Trial
NCT00727194
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Myasthenia Gravis
Intervention
eculizumab
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-24